Your browser doesn't support javascript.
loading
Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome.
Escudero-Vilaplana, V; Garcia-Gonzalez, X; Osorio-Prendes, S; Romero-Jimenez, R M; Sanjurjo-Saez, M.
Affiliation
  • Escudero-Vilaplana V; Pharmacy Department, Gregorio Marañón University General Hospital, Madrid, Spain.
  • Garcia-Gonzalez X; Pharmacy Department, Gregorio Marañón University General Hospital, Madrid, Spain.
  • Osorio-Prendes S; Hematology Department, Gregorio Marañón University General Hospital, Madrid, Spain.
  • Romero-Jimenez RM; Pharmacy Department, Gregorio Marañón University General Hospital, Madrid, Spain.
  • Sanjurjo-Saez M; Pharmacy Department, Gregorio Marañón University General Hospital, Madrid, Spain.
J Clin Pharm Ther ; 41(1): 59-63, 2016 Feb.
Article in En | MEDLINE | ID: mdl-26778738

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Benzoates / Myelodysplastic Syndromes / Iron Chelating Agents / Iron Overload Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2016 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Benzoates / Myelodysplastic Syndromes / Iron Chelating Agents / Iron Overload Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2016 Type: Article Affiliation country: Spain